Sickle Cell Disease and Thalassemia
The Sickle Cell and Thalassemia Program conducts state-of-the-art clinical and laboratory research aimed at gaining a better understanding of the diseases, preventing their complications and ultimately finding a cure. The center’s research funding is provided by government grants and the philanthropic support of a variety of community-based organizations.
Renowned for our research and therapies for blood disorders, physicians from the Sickle Cell and Thalassemia Program at Texas Children's Hospital conduct state-of-the-art clinical and scientific research aimed at understanding, preventing and curing these diseases. Texas Children's Cancer and Hematology Center is dedicated to the integration of laboratory and clinical research to increase our understanding of blood disorders, and to develop new, more effective therapies. The center receives funding through grants and philanthropic efforts of a variety of community-based organizations.
Children receiving care at Texas Children’s have the opportunity to participate in several National Institutes of Health (NIH)-funded and industry-sponsored research studies led by physician scientists, providing the latest treatments for this disease. These partnerships allow us to offer even more novel therapies to our patients.